Léim ar aghaidh chuig an bpríomhábhar

Covid-19 Pandemic

Dáil Éireann Debate, Tuesday - 21 July 2020

Tuesday, 21 July 2020

Ceisteanna (762)

John Brady


762. Deputy John Brady asked the Minister for Health if his attention has been drawn to calls for a public inquiry into the case of deaths in a nursing home (details supplied); if a public inquiry will be held into the matter; and if he will make a statement on the matter. [17357/20]

Amharc ar fhreagra

Freagraí scríofa (Ceist ar Health)

Since 2009 the Health Information and Quality Authority, HIQA, is the statutory independent regulator in place for the nursing home sector, whether a HSE managed or a private nursing home. The Authority, established under the Health Act 2007, has significant and wide-ranging powers up to and including withdrawing the registration of a nursing home facility, which means that it can no longer operate as a service provider. This responsibility is underpinned by a comprehensive quality framework comprising of Registration Regulations, Care and Welfare Regulations and National Quality Standards.

HIQA, in discharging its duties determines, through examination of all information available to it, including site inspections, whether a nursing homes meets the regulations in order to achieve and maintain its registration status. Should a nursing home be deemed to be non-compliant with the Regulations and the National Quality Standards, it may either fail to achieve or lose its registration status. In addition, the Chief Inspector has wide discretion in deciding whether to impose conditions of Registration on nursing homes.

During the response to COVID-19, Nursing homes continue to be regulated by HIQA, who under the Health Act 2007 have the legal authority to examine the operation of any facility under their remit.

Furthermore on foot of a National Public Health Emergency Team (NPHET) recommendation, on 23rd May a COVID-19 Expert Panel on Nursing Homes was established, to examine the complex issues surrounding the management of COVID-19 among this particularly vulnerable cohort.

The purpose of the Panel is to examine the national and international responses to the COVID-19 crisis, and to examine the emerging best practice. Its main objective is to provide immediate real-time learnings and recommendations in light of the expected ongoing impact of COVID-19 over the next 12-18 months. COVID-19 is a new disease, which can present atypically in the frail elderly, and new evidence and best practice in its management are constantly emerging. I expect the Expert Panel to submit their final report to me later this month.